PeriVision

📍 Lausanne, Switzerland🗓 Founded 2022👥 17 employees💰 Last funded Aug 2025
Medical Equipment Manufacturing🌐 perivision.com
Website LinkedIn
Vision is the most dominant of our senses. Yet, 2.2 billion people suffer from vision impairments of which 50% could be prevented or cured. And this number is growing due to our ageing populations and modern lifestyles. At the same time healthcare systems have limited resources. Eye care lags behind in the digital transformation and novel technology is not fully leveraged. As a result, people lose vision that do not have to. We combine AI algorithms, virtual reality and cloud computing to build the next generation systems to test visual function. We improve workflow efficiency and provide deeper clinical insight into eye diseases. To leverage these technologies fully, we take a disease-centric approach. The first condition we target is glaucoma. We address the large unmet need for more efficient and effective monitoring of 80M patients worldwide.
3
Total investors
0
Early stage
1
Mid stage
0
Late stage
2022
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Switzerland
2
Ireland
1
Investor activity2021–2025 · investors recorded per year
202112023120251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in PeriVision?
PeriVision has 3 investors on record on gritt.io, 1 mid-stage.
When did PeriVision last raise funding?
The most recent investment in PeriVision recorded on gritt.io was in August 2025.
When was PeriVision founded?
PeriVision was founded in 2022.
What industry is PeriVision in?
PeriVision operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is PeriVision based?
PeriVision is headquartered in Lausanne, Switzerland.